
Oluwatosin A. Ogunbiyi
Examiner (ID: 17664, Phone: (571)272-9939 , Office: P/1645 )
| Most Active Art Unit | 1645 |
| Art Unit(s) | 1645 |
| Total Applications | 1148 |
| Issued Applications | 603 |
| Pending Applications | 160 |
| Abandoned Applications | 405 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 17759995
[patent_doc_number] => 20220233607
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-28
[patent_title] => TOXOPLASMA PLATFORM FOR TREATING CANCER
[patent_app_type] => utility
[patent_app_number] => 17/614771
[patent_app_country] => US
[patent_app_date] => 2020-05-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27482
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17614771
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/614771 | TOXOPLASMA PLATFORM FOR TREATING CANCER | May 28, 2020 | Abandoned |
Array
(
[id] => 16451025
[patent_doc_number] => 20200360451
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-11-19
[patent_title] => FERMENTED MILK FOR IMPROVING AUTONOMIC FUNCTION
[patent_app_type] => utility
[patent_app_number] => 16/864486
[patent_app_country] => US
[patent_app_date] => 2020-05-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4739
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -3
[patent_words_short_claim] => 54
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16864486
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/864486 | FERMENTED MILK FOR IMPROVING AUTONOMIC FUNCTION | Apr 30, 2020 | Abandoned |
Array
(
[id] => 17089990
[patent_doc_number] => 11118170
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-09-14
[patent_title] => Engineered clostridium botulinum toxin adapted to deliver molecules into selected cells
[patent_app_type] => utility
[patent_app_number] => 16/854551
[patent_app_country] => US
[patent_app_date] => 2020-04-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 7977
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16854551
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/854551 | Engineered clostridium botulinum toxin adapted to deliver molecules into selected cells | Apr 20, 2020 | Issued |
Array
(
[id] => 17930161
[patent_doc_number] => 20220325286
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-13
[patent_title] => POLYPEPTIDE COMBINATION USED FOR TUMOUR IMMUNOTHERAPY, AND PREPARATION METHOD THEREFOR
[patent_app_type] => utility
[patent_app_number] => 17/605472
[patent_app_country] => US
[patent_app_date] => 2020-04-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12618
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17605472
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/605472 | Polypeptide combination used for tumour immunotherapy, and preparation method therefor | Apr 19, 2020 | Issued |
Array
(
[id] => 17735996
[patent_doc_number] => 20220221455
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-14
[patent_title] => ANTIGEN BINDING PROTEINS AND ASSAYS
[patent_app_type] => utility
[patent_app_number] => 17/604008
[patent_app_country] => US
[patent_app_date] => 2020-04-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30456
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17604008
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/604008 | ANTIGEN BINDING PROTEINS AND ASSAYS | Apr 15, 2020 | Abandoned |
Array
(
[id] => 18186310
[patent_doc_number] => 11576868
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-02-14
[patent_title] => Method for reducing zoonotic infectious diseases
[patent_app_type] => utility
[patent_app_number] => 16/848841
[patent_app_country] => US
[patent_app_date] => 2020-04-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 15058
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 150
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16848841
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/848841 | Method for reducing zoonotic infectious diseases | Apr 14, 2020 | Issued |
Array
(
[id] => 17671032
[patent_doc_number] => 20220184199
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-16
[patent_title] => IMMUNOGENIC COMPOSITIONS COMPRISING CONJUGATED CAPSULAR SACCHARIDE ANTIGENS, KITS COMPRISING THE SAME AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/601949
[patent_app_country] => US
[patent_app_date] => 2020-04-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 128838
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 60
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17601949
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/601949 | IMMUNOGENIC COMPOSITIONS COMPRISING CONJUGATED CAPSULAR SACCHARIDE ANTIGENS, KITS COMPRISING THE SAME AND USES THEREOF | Apr 5, 2020 | Abandoned |
Array
(
[id] => 19013206
[patent_doc_number] => 11920124
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-03-05
[patent_title] => Method of producing lactic acid bacteria dual-coated with protein and polysaccharide by using protein hydrolysate
[patent_app_type] => utility
[patent_app_number] => 16/839289
[patent_app_country] => US
[patent_app_date] => 2020-04-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 6
[patent_no_of_words] => 7889
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 314
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16839289
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/839289 | Method of producing lactic acid bacteria dual-coated with protein and polysaccharide by using protein hydrolysate | Apr 2, 2020 | Issued |
Array
(
[id] => 16359435
[patent_doc_number] => 20200316186
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-08
[patent_title] => MULTI-SUBUNIT VACCINES TO ELICIT BOTH MHC- AND CD1-RESTRICTED T CELL RESPONSES
[patent_app_type] => utility
[patent_app_number] => 16/839861
[patent_app_country] => US
[patent_app_date] => 2020-04-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26467
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16839861
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/839861 | Multi-subunit vaccines to elicit both MHC- and CD1-restricted T cell responses | Apr 2, 2020 | Issued |
Array
(
[id] => 17073782
[patent_doc_number] => 11110161
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-09-07
[patent_title] => Vaccine for prophylaxis or treatment of an allergen-driven airway pathology
[patent_app_type] => utility
[patent_app_number] => 16/840276
[patent_app_country] => US
[patent_app_date] => 2020-04-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 4815
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16840276
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/840276 | Vaccine for prophylaxis or treatment of an allergen-driven airway pathology | Apr 2, 2020 | Issued |
Array
(
[id] => 16539426
[patent_doc_number] => 20200405839
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-31
[patent_title] => VACCINE FORMULATION TO PROTECT AGAINST PERTUSSIS
[patent_app_type] => utility
[patent_app_number] => 16/832490
[patent_app_country] => US
[patent_app_date] => 2020-03-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10279
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16832490
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/832490 | Vaccine formulation to protect against pertussis | Mar 26, 2020 | Issued |
Array
(
[id] => 16204898
[patent_doc_number] => 20200237888
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-30
[patent_title] => COMPOSITIONS COMPRISING RECOMBINANT PROBIOTIC BACTERIA AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/813131
[patent_app_country] => US
[patent_app_date] => 2020-03-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8506
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16813131
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/813131 | COMPOSITIONS COMPRISING RECOMBINANT PROBIOTIC BACTERIA AND METHODS OF USE THEREOF | Mar 8, 2020 | Abandoned |
Array
(
[id] => 17905535
[patent_doc_number] => 11459379
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-10-04
[patent_title] => Immunoreactive protein orthologs of
[patent_app_type] => utility
[patent_app_number] => 16/809105
[patent_app_country] => US
[patent_app_date] => 2020-03-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 18
[patent_no_of_words] => 38400
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16809105
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/809105 | Immunoreactive protein orthologs of | Mar 3, 2020 | Issued |
Array
(
[id] => 16282646
[patent_doc_number] => 20200276248
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-09-03
[patent_title] => COMPOSITIONS AND METHODS FOR TREATING OR AMELIORATING COCAINE ADDICTION
[patent_app_type] => utility
[patent_app_number] => 16/804815
[patent_app_country] => US
[patent_app_date] => 2020-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12913
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16804815
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/804815 | Compositions and methods for treating or ameliorating cocaine addiction | Feb 27, 2020 | Issued |
Array
(
[id] => 17561757
[patent_doc_number] => 20220125906
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-28
[patent_title] => TREATMENT OF BENIGN NERVOUS SYSTEM TUMORS USING ATTENUATED SALMONELLA TYPHIMURIUM
[patent_app_type] => utility
[patent_app_number] => 17/434349
[patent_app_country] => US
[patent_app_date] => 2020-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14469
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17434349
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/434349 | TREATMENT OF BENIGN NERVOUS SYSTEM TUMORS USING ATTENUATED SALMONELLA TYPHIMURIUM | Feb 26, 2020 | Pending |
Array
(
[id] => 16359393
[patent_doc_number] => 20200316144
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-08
[patent_title] => BIFIDOBACTERIA FOR TREATING DIABETES AND RELATED CONDITIONS
[patent_app_type] => utility
[patent_app_number] => 16/798831
[patent_app_country] => US
[patent_app_date] => 2020-02-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13576
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16798831
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/798831 | BIFIDOBACTERIA FOR TREATING DIABETES AND RELATED CONDITIONS | Feb 23, 2020 | Abandoned |
Array
(
[id] => 18544211
[patent_doc_number] => 11717542
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-08-08
[patent_title] => Using tumor-navigating
[patent_app_type] => utility
[patent_app_number] => 17/433225
[patent_app_country] => US
[patent_app_date] => 2020-02-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 9915
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 75
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17433225
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/433225 | Using tumor-navigating | Feb 19, 2020 | Issued |
Array
(
[id] => 17967051
[patent_doc_number] => 11484556
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-11-01
[patent_title] => Nutrient rich germinant composition and spore incubation method
[patent_app_type] => utility
[patent_app_number] => 16/785138
[patent_app_country] => US
[patent_app_date] => 2020-02-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 5006
[patent_no_of_claims] => 48
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 82
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16785138
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/785138 | Nutrient rich germinant composition and spore incubation method | Feb 6, 2020 | Issued |
Array
(
[id] => 17967077
[patent_doc_number] => 11484582
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-11-01
[patent_title] => Methods and compositions for immune protection against extra-intestinal pathogenic
[patent_app_type] => utility
[patent_app_number] => 16/781526
[patent_app_country] => US
[patent_app_date] => 2020-02-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 10
[patent_no_of_words] => 21439
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 73
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16781526
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/781526 | Methods and compositions for immune protection against extra-intestinal pathogenic | Feb 3, 2020 | Issued |
Array
(
[id] => 17666400
[patent_doc_number] => 11360085
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-06-14
[patent_title] => Bacterial endotoxin test for the determination of endotoxins
[patent_app_type] => utility
[patent_app_number] => 16/774461
[patent_app_country] => US
[patent_app_date] => 2020-01-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 29
[patent_figures_cnt] => 29
[patent_no_of_words] => 27683
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 114
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16774461
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/774461 | Bacterial endotoxin test for the determination of endotoxins | Jan 27, 2020 | Issued |